HOME >> BIOLOGY >> NEWS
Sequence matters when using novel agent

TORONTO - An experimental agent that targets a cancer cell's protein shredding machinery (the proteasome) should be given either before or with taxane-based chemotherapy drugs, but not after, say researchers at The University of Texas M. D. Anderson Cancer Center who conducted laboratory tests using prostate cancer cells.

The finding is important because the new therapy, known as PS-341 (Velcade), will likely be tried as new treatment for a number of cancers due to its effectiveness in multiple myeloma, says Christos Papandreou, M.D., Ph.D., assistant professor in the department of Genitourinary Medical Oncology.

"It appears PS-341 could become quite a hit as a novel proteasome inhibitor, a drug that increases the effectiveness of chemotherapy agents," Papandreou says. "We know that while the sequence it is used in doesn't matter with certain classes of chemotherapy drugs, it does with others. Hopefully, future clinical trials will reflect this new understanding."

The findings were published in the Proceedings for the 2003 Annual Meeting of the American Association for Cancer Research.

Last summer, the agent demonstrated a dramatic success when used to treat patients with multiple myeloma. Researchers at Dana-Farber Cancer Institute, where it was tested, said 70 percent of 78 patients with advanced multiple myeloma improved - an unheard of benefit in that disease. The agent is now being used in a Phase II clinical trial in advanced prostate cancer, and several Phase I clinical trials are underway, or have been completed, testing PS-341 in pancreatic, lung and colorectal cancers.

The drug is designed to specifically inhibit proteasomes, the cell's enzymatic protein-shredding machinery, responsible for breaking down a variety of proteins, including many that regulate cell division.

M. D. Anderson researchers designed experiments in which they treated prostate cancer cells with PS-341 alone or in combination with
'"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-792-0655
University of Texas M. D. Anderson Cancer Center
9-Apr-2003


Page: 1 2

Related biology news :

1. Sequence of human chromosome 7 is fine-tuned and finished
2. Sequenced malaria genome exposes novel drug targets
3. Sequence provides insights into a pathogens virulence mechanism allowing for vaccine development
4. New Science Press launches Proteins: From Sequence to Structure
5. Sequencers take a bird in hand
6. Genetic Stowaways May Contribute To Evolutionary Change: Adjacent Sequences Tag Along With Mobile DNA Elements, Study Shows
7. Scientists Sequence Chlamydia Trachomatis Genome
8. New Insights On Sequence of Cell Death After Brain Injury: Understanding Cellular Events After Brain Trauma Could Lead To Better Therapies
9. Syphilis Genome Sequence Offers Clues To Better Diagnosis, Prevention And Treatment
10. Why some animals have smaller eyes: Lifestyle matters
11. Why genetic diversity matters

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2019)... ... 2019 , ... Serialization deadlines in the US and European ... aggregation becomes fully applied in the United States in 2023, pharmaceutical companies are ... now, most regulations?including the Drug Supply Chain Security Act (DSCSA)?have required minimal system ...
(Date:8/14/2019)... ... 14, 2019 , ... Representatives with MyBioGate announced that China Focus@Biotech Week will ... “We help innovative projects connect with Chinese pharma and investors in healthcare innovation,” said ... to explain that as a part of Biotech Week Boston – the annual biotech ...
(Date:8/6/2019)... ... August 06, 2019 , ... A study released today ... have far-reaching implications for personalized medicine, especially when seeking treatments for children with ... predict which stem cell donors and manipulation methods might yield the best therapies ...
Breaking Biology News(10 mins):
(Date:7/11/2019)... ... July 11, 2019 , ... At the most recent stem ... to eight military Veterans under the R3 Heroes Program. The Veterans included individuals and ... Heroes Program allow anyone to nominate a military Veteran, teacher or first responder to ...
(Date:7/9/2019)... , ... July 08, 2019 , ... ... The company’s SmartLight Indicator was recognized as the 2019 Innovative Product of the ... forward. The prestigious awards were during Sensors Expo & Conference 2019, ...
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research results ... properties of Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , ... differentiation peak, change in crystallite size , Over 142% increase in particle ...
(Date:6/18/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, ... a person’s own adipose-derived stem cells to treat their osteoarthritis. The first clinical trial ... is the first of several planned clinical trials which will enable qualified PSC-enrolled physicians ...
Breaking Biology Technology:
Cached News: